Abstract
Calcium antagonists exhibit direct antiatherosclerotic action in primary culture of human aortic atherosclerotic cells by lowering intracellular lipid content, proliferative activity and synthesis of the extracellular matrix. Verapamil exhibited the highest efficacy in this respect. New calcium antagonist, anipamil, and its enantiomers have been tested in cell culture. At 10-6 M and higher concentrations, anipamil and its enantiomers produced considerable decrease in intracellular contents of cholesteryl esters, triglycerides and free cholesterol, suppressed cell proliferation and inhibited synthesis of the extracellular matrix. The efficacy of anipamil enantiomers and racemate was similar to that of verapamil. Blood plasma obtained from patients after administration of 80 mg verapamil or 20 mg nifedipin significantly lowered the cholesterol content of cultured cells. Blood plasma of most atherosclerotic patients possesses atherogenic properties, i.e. it is able to increase cholesterol content in cultured cells. Plasma atherogenicity manifested in culture decreased considerably or even disappeared after both nifedipine and verapamil administration. After 28 days of nifedipine therapy, plasma atherogenenicity was lower compared with the initial value at the beginning of the treatment. These observations suggest that control of plasma atherogenicity after drug administration may provide an additional tool for optimization of direct antiatherogenic and antiatherosclerotic therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blumlein, S.L., Sievers, R., Kidd, P. and Parmley. W.W. (1985) “Modification of experimental atherosclerosis by calcium-channel blockers”, Am. J. Cardiol., 55, 165B–171B.
Kober, G., Schneider, W. and Kaltenbach, M. (1989) “Can the progression of coronary sclerosis be influenced by calcium antagonists?”, J. Cardiovasc. Pharmacol., 13. S2–S6.
Lichtlen, P.R., Hugenholtz, P.G., Rafflenbeul, W. and INTACT-group (1989) “Possible protective effect of nifedipine against pro gression of atherosclerosis in man (INTACT-study)”, in Abstract Book, 4th International Symposium on Calcium Antagonists: Pharmacology and Clinical Research, Florence (Italy), May 25–27, 1989, pp. 127–130
Orekhov, A.N., Tertov, V.V., Kudryashov, S.A., Khashimov, Kh.A. and Smirnov, V.N. (1986) “Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and Lipid-lowering agents”, Atherosclerosis, 60, 101–110.
Orekhov, A.N., Tertov, V.V., Khashimov, Kh.A., Kudryashov, S.A. and Smirnov, V.N. (1986) “Antiatherosclerotic effects of verapamil in primary culture of human aortic intimai cells”, J. Hypertension, 4, S153–S155.
Orekhov, A.N., Tertov, V.V., Khashimov, Kh.A., Kudryashov, S.A. and Smirnov, V.N. (1987) “Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells”, Am. J. Cardiol., 59, 495–496.
Orekhov, A.N., Baldenkov, G.N., Tertov, V.V., Li Hwa Ryong, Kozlov, S.G., Lyakishev, A.A., Tkachuk, V.A., Ruda, M.Ya. and Smirnov, V.N. (1988) “Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells”, J. Cardiovasc. Pharmacol., 12, S66–S68.
Baldenkov, G.N., Akopov, S.E., Li, H.R. and Orekhov, A.N. (1988) “Prostacyclin, thromboxane A2 and calcium antagonists: effects on atherosclerotic characteristics of vascular cells”, Biomed. Biochim. Acta, 47, S324–S327.
Orekhov, A.N., Tertov, V.V., Novikov, I.D., Krushinsky, A.V., Andreeva, E.R., Lankin, V.Z. and Smirnov, V.N. (1985) “Lipids in cells of atherosclerotic and uninvolved human aorta. I. Lipid composition of aortic tissue and enzyme isolated and cultured cells”, Exp. Mol. Pathol., 42, 117–137.
Bligh, E.G. and Dyer, W.J. (1959) “A rapid method of total lipid extraction and purification”, Can. J. Biochem. Physiol., 37, 911–917.
Dixon, W.J. and Brown, M.B. (1977) Biomedical Computer Programs. P-Series, University of California Press, Berkeley, pp. 185–198.
Chazov, E.I., Tertov, V.V., Orekhov, A.N., Lyakishev, A.A., Perova, N.V., Kurdanov, Kh.A., Khashimov, Kh.A., Novikov, I.D. and Smirnov, V.N. (1986) “Atherogenicity of blood serum from patients with coronary heart disease”, Lancet, 2, 595–598.
Orekhov, A.N., Tertov, V.V., Pokrovsky, S.N., Adamova, I.Yu., Martsenyuk, O.N., Lyakishev, A.A. and Smirnov. V.N. (1988) “Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination”, Circ. Res., 62, 421–429.
Chazov, E.I., Orekhov, A.N., Tertov, V.V., Pokrovsky, S.N., Adamova, I.Yu., Lyakishev, A.A., Gratsianski, N.A., Nechaev, A.S., Perova, N.V., Khashimov, Kh.A., Kurdanov, Kh.A., Kukharchuk, V.V. and Smirnov, V.N. (1988) “Atherogenicity of blood plasma from patients with coronary atherosclerosis and its correction”, Atherosclerosis Rev., 17, 9–20.
Tertov, V.V., Orekhov, A.N., Martsenyuk, O.N., Perova, N.V. and Smirnov, V.N. (1989) “Low density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells”, Exp. Mol. Pathol. 50, 337–347.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Orekhov, A.N., Tertov, V.V., Kozlov, S.G., Lyakishev, A.A., Ruda, M.Y. (1990). Antiatherosclerotic effects of anipamil, verapamil and other calcium antagonists studied on cell culture. In: Descovich, G., Gaddi, A., Magri, G., Lenzi, S. (eds) Atherosclerosis and Cardiovascular Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0731-7_47
Download citation
DOI: https://doi.org/10.1007/978-94-009-0731-7_47
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6814-7
Online ISBN: 978-94-009-0731-7
eBook Packages: Springer Book Archive